FDA gave another indication of what its forthcoming social media guidance on sponsored links will look like in citing Gilead Sciences Inc. for its Viread (tenofovir disoproxil fumarate) link.
In a June 27 letter, FDA’s Office of Prescription Drug Promotion objected to the “Hepatitis B Prevention” claim...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?